Globe Newswire (Tue, 14-Jul 4:36 PM ET)
Newsfile (Mon, 13-Jul 12:19 PM ET)
Globe Newswire (Mon, 13-Jul 12:12 PM ET)
Business Wire (Mon, 13-Jul 9:17 AM ET)
Newsfile (Sun, 12-Jul 11:16 AM ET)
PRNewswire (Sat, 11-Jul 10:05 AM ET)
Newsfile (Sat, 11-Jul 8:16 AM ET)
Globe Newswire (Fri, 10-Jul 3:34 PM ET)
Business Wire (Fri, 10-Jul 11:19 AM ET)
Globe Newswire (Fri, 10-Jul 9:00 AM ET)
Phreesia Inc is a provides an integrated software, payments, and engagement platform designed to address three foundational challenges in healthcare delivery: access to care, affordability of care, and patient health outcomes. Its platform is embedded directly into provider workflows and patient interactions, enabling healthcare organizations to activate patients, streamline administrative processes, and improve financial performance across the care continuum. The group serves a diverse group of healthcare organizations, including ambulatory practices, health systems, and hospitals, as well as life sciences companies, government entities, patient advocacy, public interest, and not-for-profit and other organizations.
Phreesia trades on the NYSE stock market under the symbol PHR.
As of July 15, 2026, PHR stock price climbed to $10.76 with 502,738 million shares trading.
PHR has a beta of 0.86, meaning it tends to be less sensitive to market movements. PHR has a correlation of 0.03 to the broad based SPY ETF.
PHR has a market cap of $664.69 million. This is considered a Small Cap stock.
Last quarter Phreesia reported $131 million in Revenue and $.05 earnings per share. This beat revenue expectation by $823,792 and missed earnings estimates by -$.18.
In the last 3 years, PHR traded as high as $34.28 and as low as $7.77.
The top ETF exchange traded funds that PHR belongs to (by Net Assets): VTI, IWM, VXF, FESM, IWO.
PHR has underperformed the market in the last year with a return of -61.0%, while SPY returned +22.0%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in PHR shares. However, PHR has outperformed the market in the last 3 month and 2 week periods, returning +25.1% and +4.6%, while SPY returned +9.0% and +1.1%, respectively. This indicates PHR has been having a stronger performance recently.
PHR support price is $10.35 and resistance is $11.13 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that PHR shares will trade within this expected range on the day.
